Dyslipidemia following kidney transplantation: diagnosis and treatment (Q37565707)

21 August 2017

1 reference

title

Dyslipidemia following kidney transplantation: diagnosis and treatment (English)

1 reference

21 August 2017

0 references

1 reference

kidney transplantation

1 reference

Stéphanie Badiou

1

1 reference

PubMed ID

19640344

21 August 2017

Jean-Paul Cristol

series ordinal

2

1 reference

PubMed ID

19640344

21 August 2017

Georges Mourad

series ordinal

3

1 reference

21 August 2017

1 August 2009

1 reference

21 August 2017

Current diabetes report

1 reference

21 August 2017

9

1 reference

21 August 2017

4

1 reference

21 August 2017

305-311

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-009-0047-0

21 August 2017

0 references

cites work

A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-009-0047-0

Compared effect of immunosuppressive drugs cyclosporine A and rapamycin on cholesterol homeostasis key enzymes CYP27A1 and HMG-CoA reductase.

21 January 2018

1 reference

12 December 2020

Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients

1 reference

12 December 2020

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

12 December 2020

Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients

1 reference

12 December 2020

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

1 reference

12 December 2020

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation

1 reference

12 December 2020

Statin use is associated with prolonged survival of renal transplant recipients.

1 reference

12 December 2020

Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure

1 reference

12 December 2020

Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia

1 reference

12 December 2020

Benefits of a dietary intervention on weight loss, body composition, and lipid profile after renal transplantation

1 reference

12 December 2020

Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study

1 reference

12 December 2020

Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study

1 reference

12 December 2020

Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation

1 reference

12 December 2020

New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?

1 reference

12 December 2020

Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia

1 reference

12 December 2020

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

1 reference

12 December 2020

Comparison of serum lipids, lipoproteins, and fibrinogen in patients with kidney transplantation and hemodialysis.

1 reference

12 December 2020

The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.

1 reference

12 December 2020

Reduced exposure to calcineurin inhibitors in renal transplantation

1 reference

12 December 2020

Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients

1 reference

12 December 2020

Metabolic syndrome after kidney transplantation

1 reference

12 December 2020

Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids

1 reference

12 December 2020

Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?

1 reference

12 December 2020

Corticosteroid elimination: the Cincinnati experience.

1 reference

12 December 2020

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality

1 reference

12 December 2020

Cyclosporine A and Rapamycin induce in vitro cholesteryl ester transfer protein activity, and suppress lipoprotein lipase activity in human plasma

1 reference

12 December 2020

Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study

1 reference

12 December 2020

Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6-Month Course of Steroids

1 reference

12 December 2020

Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals

1 reference

12 December 2020

Patient survival after renal transplantation III: the effects of statins

1 reference

12 December 2020

Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids

1 reference

12 December 2020

Ezetimibe treatment in hypercholesterolemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: a pilot study

1 reference

12 December 2020

Immunosuppression enhances atherogenicity of lipid profile after transplantation

1 reference

12 December 2020

Cardiovascular toxicities of immunosuppressive agents

1 reference

12 December 2020

Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation

1 reference

12 December 2020

Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study

1 reference

12 December 2020

Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels

1 reference

12 December 2020

The effects of hyperlipidaemia on graft and patient outcome in renal transplantation

1 reference

12 December 2020

Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus

1 reference

12 December 2020

Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients

1 reference

12 December 2020

Protective Effect of the Immunosuppressant Sirolimus Against Aortic Atherosclerosis In Apo E-Deficient Mice

1 reference

12 December 2020

Fenofibrate-associated reversible acute allograft dysfunction in 3 renal transplant recipients: biopsy evidence of tubular toxicity

1 reference

12 December 2020

Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile

1 reference

12 December 2020

Role of dietary intervention on metabolic abnormalities and nutritional status after renal transplantation.

1 reference

12 December 2020

Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study

1 reference

12 December 2020

10.1007/S11892-009-0047-0

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19640344